单位：[1]Nanfang Hospital, Southern MedicalUniversity, CHESS Group,Hepatic Hemodynamic Lab, Institute ofHepatology, Guangzhou, China[2]Beth Israel Deaconess Medical Center,Harvard Medical School, Division of Gastroenterology and Hepatology,Boston, China[3]Lanzhou University, CHESS Frontier Center, Lanzhou,China[4]The Fifth Medical Center of Chinese PLA General Hospital,Department of General Surgery, Beijing, China[5]Beijing ShijitanHospital, Capital Medical University, Department of InterventionalTherapy, Beijing, China[6]Beijing Friendship Hospital, Capital MedicalUniversity, Institute of Hepatology, Beijing, China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[7]Shandong ProvincialHospital, Shandong University, Department of Gastroenterology,Jinan, China
第一作者单位：[1]Nanfang Hospital, Southern MedicalUniversity, CHESS Group,Hepatic Hemodynamic Lab, Institute ofHepatology, Guangzhou, China[2]Beth Israel Deaconess Medical Center,Harvard Medical School, Division of Gastroenterology and Hepatology,Boston, China[3]Lanzhou University, CHESS Frontier Center, Lanzhou,China
推荐引用方式(GB/T 7714)：
Qi Xiaolong,Li Wenda,Huang Pinzhu,et al.Von Willebrand factor a non-invasive serum biomarker of portal pressure in cirrhosis: Evidence in human and rodent[J].JOURNAL of HEPATOLOGY.2019,70(1):E823-E824.doi:10.1016/S0618-8278(19)31646-9.
APA：
Qi, Xiaolong,Li, Wenda,Huang, Pinzhu,Lin, Xinlong,Zeng, Xiangbo...&Yury, Popov.(2019).Von Willebrand factor a non-invasive serum biomarker of portal pressure in cirrhosis: Evidence in human and rodent.JOURNAL of HEPATOLOGY,70,(1)
MLA：
Qi, Xiaolong,et al."Von Willebrand factor a non-invasive serum biomarker of portal pressure in cirrhosis: Evidence in human and rodent".JOURNAL of HEPATOLOGY 70..1(2019):E823-E824
医学